Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG for GVHD Prophylaxis in Older Patients After Allo-SCT
NCT01856803Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2013
- Primary completion
- Jun 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin in graft-versus-host disease (GVHD), sponsored by Peking University People's Hospital. Started Oct 2013; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01856803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856803.